drugset / Trial / NCT00072787
Phase 1/2 Study of S-1 and Cisplatin in Advanced Gastric Cancer
Non-randomizedSingle-groupOpen-labelTreatment
Summary
The purpose of the phase 1 portion of the study is to determine the safe dose of S-1 and cisplatin that can be administered in gastric cancer patients. The purpose of the phase 2 portion of the study is to determine the antitumor activity of the S-1 and cisplatin regimen established from phase 1 in patients with advanced gastric cancer.
Timeline
- Start
- 2003-10
- Primary completion
- 2006-03
- Completion
- 2006-05
Drugs
| Evaluation | Drug | Modality | Dose | Route |
|---|---|---|---|---|
| Subject | Cisplatin | Other / unclassified | — | — |
| Subject | S-1 | Small molecule | — | Oral |